An economic comparison of three cell culture techniques: Fed-batch, concentrated fed-batch, and concentrated perfusion

BioPharm International

Volumn 24, Issue 2, 2011, Pages 54-60

  Lim, Janice ^a   Sinclair, Andrew ^a   Shevitz, Jerry ^b   Carter, John Bonham ^b  

^a BioPharm Services UK   (United Kingdom)

^b Refining Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED PROTEIN;

ARTICLE; BIOREACTOR DESIGN; CELL CULTURE; CELL SEPARATION; CENTRIFUGATION; COMPUTER PROGRAM; CONCENTRATED PERFUSION CULTURE; DIAFILTRATION; ECONOMIC EVALUATION; FED BATCH CULTURE; FINANCIAL MANAGEMENT; INTERMETHOD COMPARISON; MAMMAL CELL; NONHUMAN; PROTEIN SYNTHESIS; SCALE UP; ULTRAFILTRATION;

EID: 79952456491     PISSN: 1542166X     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (6)

1. Chu L, Robinson DK. Industrial choices for protein production by large-scale cell culture. Curr Opin Biotechnol. 2001;12:180-187. (Pubitemid 32247406)
2. Carstens, Jason. Perfusion! Jeopardy or the Ultimate Advantage? BioProcess International webinar. 2009 Sept.
3. Furey J. Scale-up of a cell culture perfusion process. Gen Eng News. 2002;22:62.
4. Mora J, Sinclair A, Delmdahl N, Gottschalk U. Disposable membrane chromatography performance analysis and economic cost model. Bioprocess Int Suppl. 2006:4:38-43.
5. Lim JAC, Sinclair A, Kim DS, Gottschalk U. Economic benefits of single-use membrane chromatography in polishing-A cost of goods model. Bioprocess Int. 2007;5(2)48-56.
6. Noe W. Paradigm changes and technology gaps in the biopharmaceutical industry. BioProcess International Conference & Exhibition; 2009 October 12-15; Raleigh, NC, USA.